Exact Mass: 340.1946

Exact Mass Matches: 340.1946

Found 186 metabolites which its exact mass value is equals to given mass value 340.1946, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pentamidine

American pharmaceutical partners brand 1 OF pentamidine isethionate

C19H24N4O2 (340.1899)


Pentamidine is only found in individuals that have used or taken this drug. It is an antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of pneumocystis pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. [PubChem]The mode of action of pentamidine is not fully understood. It is thought that the drug interferes with nuclear metabolism producing inhibition of the synthesis of DNA, RNA, phospholipids, and proteins. D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Mepenzolate

Mepenzolic acid, bromine salt, 1-(methyl-(14)C)-labeled

C21H26NO3+ (340.1913)


Mepenzolate is a post-ganglionic parasympathetic inhibitor. It decreases gastric acid and pepsin secretion and suppresses spontaneous contractions of the colon. Mepenzolate diminishes gastric acid and pepsin secretion. Mepenzolate also suppresses spontaneous contractions of the colon. Pharmacologically, it is a post-ganglionic parasympathetic inhibitor. It has not been shown to be effective in contributing to the healing of peptic ulcer, decreasing the rate of recurrence, or preventing complications. A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Methantheline

diethyl(methyl)[2-(9H-xanthene-9-carbonyloxy)ethyl]azanium

C21H26NO3+ (340.1913)


Methantheline is a synthetic antispasmodic. Antispasmodics are used to relieve cramps or spasms of the stomach, intestines, and bladder. Methantheline is used to treat intestine or stomach ulcers (peptic ulcer disease), intestine problems (irritable bowel syndrome), pancreatitis, gastritis, biliary dyskinesia, pylorosplasm, or urinary problems (reflex neurogenic bladder in children). A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Norethindrone acetate

Norethindrone acetate; Norethisterone acetate

C22H28O3 (340.2038)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

NCIOpen2_008030

17-Hydroxy-3-oxo-17alpha-pregna-1,4-diene-21-carboxylic acid, gamma-lactone

C22H28O3 (340.2038)


   

Perindoprilat

(2S,3aS,7aS)-1-[(2S)-2-{[(1S)-1-carboxybutyl]amino}propanoyl]-octahydro-1H-indole-2-carboxylic acid

C17H28N2O5 (340.1998)


Perindoprilat is a metabolite of perindopril. Perindopril, or perindopril arginine, (trade names include Coversyl and Aceon) is a long-acting ACE inhibitor. Perindopril is used to treat high blood pressure, heart failure or stable coronary artery disease. It is also available in a generic form, perindopril erbumine. (Wikipedia) D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-[(3-Methylphenyl)amino]pyrimidine-5-Carboxamide

2-{[(1r,2s)-2-Aminocyclohexyl]amino}-4-[(3-Methylphenyl)amino]pyrimidine-5-Carboxamide

C18H24N6O (340.2011)


   

pentamidine

pentamidine

C19H24N4O2 (340.1899)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents C254 - Anti-Infective Agent > C276 - Antiparasitic Agent > C277 - Antiprotozoal Agent D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent [Raw Data] CB201_Pentamidine_pos_50eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_40eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_30eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_20eV_isCID-10eV_rep000006.txt [Raw Data] CB201_Pentamidine_pos_10eV_isCID-10eV_rep000006.txt KEIO_ID P209; [MS2] KO009179 KEIO_ID P209; [MS3] KO009180 KEIO_ID P209

   

Canrenone

(1S,2R,2R,10R,11S,15S)-2,15-dimethylspiro[oxolane-2,14-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecane]-6,8-diene-5,5-dione

C22H28O3 (340.2038)


Canrenone is the major metabolite of spironolactone. Spironolactone is a competitive aldosterone receptor antagonist (ARA), has traditionally been the treatment of first choice in idiopathic hyperaldosteronism (IHA) and for preoperative management of aldosterone producing adenoma (APA), and its therapeutic properties are attributable to active metabolite canrenone. Canrenone and the K+ salt of canrenoate are also in clinical use: they avoid the formation of intermediate products with anti-androgenic and progestational actions, resulting in a decreased incidence of side effects. (PMID: 10790593) [HMDB] Canrenone is the major metabolite of spironolactone. Spironolactone is a competitive aldosterone receptor antagonist (ARA), has traditionally been the treatment of first choice in idiopathic hyperaldosteronism (IHA) and for preoperative management of aldosterone producing adenoma (APA), and its therapeutic properties are attributable to active metabolite canrenone. Canrenone and the K+ salt of canrenoate are also in clinical use: they avoid the formation of intermediate products with anti-androgenic and progestational actions, resulting in a decreased incidence of side effects. (PMID:10790593). D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.

   

Piperochromenoic acid

2-(4,8-Dimethyl-3,7-nonadienyl)-2-methyl-2H-1-benzopyran-6-carboxylic acid, 9ci

C22H28O3 (340.2038)


Piperochromenoic acid is found in herbs and spices. Piperochromenoic acid is a constituent of the leaves of Piper auritum (Veracruz pepper). Constituent of the leaves of Piper auritum (Veracruz pepper). Piperochromenoic acid is found in herbs and spices.

   

11-Dehydro-2,3-dinor-txb2

5-[4-hydroxy-2-(3-hydroxyoct-1-en-1-yl)-6-oxooxan-3-yl]pent-3-enoic acid

C18H28O6 (340.1886)


   

3-[2-(3-Guanidino-2-methyl-3-oxo-propenyl)-5-methyl-phenyl]-N-isopropylidene-2-methyl-acrylamide

N-(diaminomethylidene)-2-methyl-3-(4-methyl-2-{2-methyl-2-[(propan-2-ylidene)carbamoyl]eth-1-en-1-yl}phenyl)prop-2-enamide

C19H24N4O2 (340.1899)


   

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

C22H29OP (340.1956)


   

Glycyl-l-histidyl-l-lysine

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

C14H24N6O4 (340.1859)


   

Norethindrone acetate

14-ethynyl-15-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl acetate

C22H28O3 (340.2038)


   

Pexacerfont

N-(butan-2-yl)-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine

C18H24N6O (340.2011)


   

Spirolactone SC 14266

2,15-dimethylspiro[oxolane-2,14-tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecane]-6,8-diene-5,5-dione

C22H28O3 (340.2038)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

Peperobtusin B

Peperobtusin B

C22H28O3 (340.2038)


   

Sucutinirane C

Sucutinirane C

C22H28O3 (340.2038)


   

Gaudichaudianic acid

(+)-Gaudichaudianic acid

C22H28O3 (340.2038)


   

14-(4-Hydroxybenzoyloxy)dauc-4,8-diene

(+)-14-(4-Hydroxybenzoyloxy)dauc-4,8-diene

C22H28O3 (340.2038)


   

Oprea1_757720

Oprea1_757720

C22H28O3 (340.2038)


   

Oprea1_743991

Oprea1_743991

C22H28O3 (340.2038)


   

p-Hydroxyphenethyl anisate

p-Hydroxyphenethyl anisate

C21H26NO3 (340.1913)


   

Poldine

Poldine

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

MCULE-3035603698

MCULE-3035603698

C18H28O6 (340.1886)


   

5-carboxy-2,3-dihydro-2-(1,5-dimethyl-1E,4-hexadienyl)-7-(3-methyl-2-butenyl)benzofuran|myrsinoic acid F

5-carboxy-2,3-dihydro-2-(1,5-dimethyl-1E,4-hexadienyl)-7-(3-methyl-2-butenyl)benzofuran|myrsinoic acid F

C22H28O3 (340.2038)


   
   

gamahonolide B

gamahonolide B

C18H28O6 (340.1886)


   

likonide B|smenochromene D

likonide B|smenochromene D

C22H28O3 (340.2038)


   

alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone

alpha-o-methylbotrydialone|alpha-O-methyldihydrobotrydialone

C18H28O6 (340.1886)


   

1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose

1, 2:4, 5-Di-O-cyclohexylidene-beta-D-Pyranose-Fructose

C18H28O6 (340.1886)


   

Pestalotiopsin A

Pestalotiopsin A

C18H28O6 (340.1886)


   

2-[(2E,6E)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dienyl]-5-methylbenzene-1,4-diol|Furanoquinol

2-[(2E,6E)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dienyl]-5-methylbenzene-1,4-diol|Furanoquinol

C22H28O3 (340.2038)


   

11-dehydro-2,3-dinor Thromboxane B2

9α,15S-dihydroxy-11-oxo-2,3-dinor-thromba-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

kurubasch aldehyde benzoate

kurubasch aldehyde benzoate

C22H28O3 (340.2038)


   

1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester

1beta,4beta-dihydroxy-8beta-acetoxy-5alphaH-eudesma-11(13)-en-12-oic acid methyl ester

C18H28O6 (340.1886)


   

1,2:5,6-di-o-cyclohexylidene-myo-inositol

1,2:5,6-di-o-cyclohexylidene-myo-inositol

C18H28O6 (340.1886)


   

5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate

5-Ac,Me ether-4,5,10-Trihydroxy-11(13)-amorphen-12-oic acid|methyl 5-acetoxy-4,5-dihydro-4,10-dihydroxy-5-acetoxyartemisinate

C18H28O6 (340.1886)


   

20-methoxy-1,4,17(20)E-pregnatriene-3,16-dione|dehydroguggulsterone M

20-methoxy-1,4,17(20)E-pregnatriene-3,16-dione|dehydroguggulsterone M

C22H28O3 (340.2038)


   

Kneglomeratanone A

Kneglomeratanone A

C22H28O3 (340.2038)


   

dehydrofurodendin

dehydrofurodendin

C22H28O3 (340.2038)


   

methyl acetylbotryaloate

methyl acetylbotryaloate

C18H28O6 (340.1886)


   

Gaudichaudianic acid, (-rac)

Gaudichaudianic acid, (-rac)

C22H28O3 (340.2038)


A natural product found in Piper gaudichaudianum.

   

8-[(2E)-3,7-dimethyl-2,6-octadienyl]-2,2-dimethyl-2H-chromene-6-carboxylic acid|cumanensic acid

8-[(2E)-3,7-dimethyl-2,6-octadienyl]-2,2-dimethyl-2H-chromene-6-carboxylic acid|cumanensic acid

C22H28O3 (340.2038)


   
   
   
   

3,11beta-Dimethoxy-19-nor-17alpha-pregna-1,3,5(10)trien-20-yn-17beta-ol

3,11beta-Dimethoxy-19-nor-17alpha-pregna-1,3,5(10)trien-20-yn-17beta-ol

C22H28O3 (340.2038)


   
   

8alpha-benzoyloxyspathulenol

8alpha-benzoyloxyspathulenol

C22H28O3 (340.2038)


   

8alpha-benzoyloxy-4,15-epoxycaryophyllene

8alpha-benzoyloxy-4,15-epoxycaryophyllene

C22H28O3 (340.2038)


   

NCI60_018217

NCI60_018217

C22H28O3 (340.2038)


   
   
   

Copper Peptide(GHK-Cu, GHK-Copper)

Copper Peptide(GHK-Cu, GHK-Copper)

C14H24N6O4 (340.1859)


   

Canrenone

Canrenone

C22H28O3 (340.2038)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D000451 - Mineralocorticoid Receptor Antagonists C - Cardiovascular system > C03 - Diuretics > C03D - Aldosterone antagonists and other potassium-sparing agents > C03DA - Aldosterone antagonists C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49186 - Potassium-Sparing Diuretic COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2394 INTERNAL_ID 2394; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8731 INTERNAL_ID 8731; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 4164 Canrenone (Aldadiene) is an aldosterone antagonist extensively used as a diuretic agent.

   

Poldine

Poldine

[C21H26NO3]+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

19-Norethindrone acetate

19-Norethindrone acetate

C22H28O3 (340.2038)


   

MLS001304004-01!Norethindrone Acetate

MLS001304004-01!Norethindrone Acetate

C22H28O3 (340.2038)


   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

C18H28O6 (340.1886)


   
   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate

C18H28O6 (340.1886)


   
   

Perindoprilat

Perindoprilat (diacid form)

C17H28N2O5 (340.1998)


A dipeptide obtained by formal condensation of one of the carboxy groups of N-[(1S)-1-carboxyethyl]-L-norvaline with the amino group of (2S,3aS,7aS)-octahydroindole-2-carboxylic acid. The major active metabolite of perindopril. D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based on: CCMSLIB00000848998]

C18H28O6 (340.1886)


   

[5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]

NCGC00347635-02![5-acetyloxy-3-(hydroxymethyl)-2-oxo-6-propan-2-ylcyclohex-3-en-1-yl] 3-methylpentanoate [IIN-based: Match]

C18H28O6 (340.1886)


   
   
   
   

D1-2-Hydroxymethylethisterone

D1-2-Hydroxymethylethisterone

C22H28O3 (340.2038)


   
   
   

2,3-Dinor-6-keto-PGF1a

2,3-Dinor-6-keto-PGF1a

C18H28O6 (340.1886)


   

11-dehydro-2,3-dinor-TXB2

2,3-dinor-9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

methantheline

Banthine Bromide;Methantheline Bromide;Methanthelinium;Methanthelinium Bromide;Methanthelinum;Methanthine Bromide;MTB 51

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists

   

Piperochromenoic acid

2-(4,8-Dimethyl-3,7-nonadienyl)-2-methyl-2H-1-benzopyran-6-carboxylic acid, 9ci

C22H28O3 (340.2038)


   

FA 18:4;O4

2,3-dinor-9S,15S-dihydroxy-11-oxo-thromboxa-5Z,13E-dien-1-oic acid

C18H28O6 (340.1886)


   

Copper Peptide

Glycyl-l-histidyl-l-lysine

C14H24N6O4 (340.1859)


Glycyl-L-histidyl-L-lysine is a tripeptide consisting of glycine, L-histidine and L-lysine residues joined in sequence. Glycyl-L-histidyl-L-lysine is a hepatotropic immunosuppressor and shows anxiolytic effect. Glycyl-L-histidyl-L-lysine and its copper complexes show good skin tolerance[1][2][3].

   

1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE

1,2:5,6-DI-O-CYCLOHEXYLIDENE-3-CYANO-ALPHA-D-ALLOFURANOSE

C18H28O6 (340.1886)


   

1-[4-(4-methylcyclohexyl)cyclohexyl]-4-(trifluoromethoxy)benzene

1-[4-(4-methylcyclohexyl)cyclohexyl]-4-(trifluoromethoxy)benzene

C20H27F3O (340.2014)


   

1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose

1,2:5,6-Di-O-cyclohexylidene-alpha-D-glucofuranose

C18H28O6 (340.1886)


   

(3R)-1-(3-CHLOROPYRIDIN-2-YL)-3-METHYLPIPERAZINE

(3R)-1-(3-CHLOROPYRIDIN-2-YL)-3-METHYLPIPERAZINE

C21H28O2Si (340.1858)


   

9-Acridineethanamine,N-(1-methyl-2-phenylethyl)-

9-Acridineethanamine,N-(1-methyl-2-phenylethyl)-

C24H24N2 (340.1939)


   

[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester

[6-(4-methyl-piperazin-1-yl)-4-o-tolylpyridin-3-yl]-carbamic acid methyl ester

C19H24N4O2 (340.1899)


   

4-Butoxyphenyl 4-Pentylbenzoate

4-Butoxyphenyl 4-Pentylbenzoate

C22H28O3 (340.2038)


   

CarboxyMethylcellulose sodiuM

CarboxyMethylcellulose sodiuM

C19H24N4O2 (340.1899)


   

(2S)-5-(tert-butyldiphenylsilyloxy)-1,2-epoxypentane

(2S)-5-(tert-butyldiphenylsilyloxy)-1,2-epoxypentane

C21H28O2Si (340.1858)


   

(2R,5S)-rel-Tetrahydro-5-propyl-2-[trans-4-(3,4,5-trifluorophenyl)cyclohexyl]-2H-pyran

(2R,5S)-rel-Tetrahydro-5-propyl-2-[trans-4-(3,4,5-trifluorophenyl)cyclohexyl]-2H-pyran

C20H27F3O (340.2014)


   

4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl

4-Chloro-4-(trans-4-pentylcyclohexyl)-1,1-biphenyl

C23H29Cl (340.1958)


   

2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE

2,3:5,6-DI-O-CYCLOHEXYLIDENE-ALPHA-D-MANNOFURANOSE

C18H28O6 (340.1886)


   

4,4-Methylenebis(1,1-dimethyl-3-phenylurea)

4,4-Methylenebis(1,1-dimethyl-3-phenylurea)

C19H24N4O2 (340.1899)


   

Pexacerfont

Pexacerfont

C18H24N6O (340.2011)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

Penthienate

Penthienate

C18H30NO3S+ (340.1946)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds

   

Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-

Phosphine oxide, [5-methyl-2-(1-methylethyl)cyclohexyl]diphenyl-

C22H29OP (340.1956)


   

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

[[(1S,2S,5R)-5-Methyl-2-propan-2-ylcyclohexyl]-phenylphosphoryl]benzene

C22H29OP (340.1956)


   

Bohemine

Bohemine

C18H24N6O (340.2011)


Bohemine is a purine analogue and is a synthetic and selective CDK inhibitor with IC50s of 4.6 μM, 83 μM, and 2.7 μM for Cdk2/cyclin E, Cdk2/cyclin A, and Cdk9/cyclin T1, respectively. Bohemine also inhibits ERK2 with an IC50 of 52 μM and has less inhibitory effect on CDK1, CDK4 and CDK6. Bohemine has a broad spectrum anti-cancer activities[1][2].

   

1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine

1-[2-(3,4-dihydro-1H-2-benzopyran-1-yl)ethyl]-4-(4-fluorophenyl)piperazine

C21H25FN2O (340.1951)


   

Parapenzolate

Parapenzolate

C21H26NO3+ (340.1913)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

L-Histidine, N-(N(2)-glycyl-L-lysyl)-

L-Histidine, N-(N(2)-glycyl-L-lysyl)-

C14H24N6O4 (340.1859)


   
   

L-Lysine, N2-(N-L-histidylglycyl)-

L-Lysine, N2-(N-L-histidylglycyl)-

C14H24N6O4 (340.1859)


   

DES(2-methylbutanoyl)pravastatin

DES(2-methylbutanoyl)pravastatin

C18H28O6 (340.1886)


   

(8r,9s,10r,13s,14s,17r)-10,13-Dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3h-spiro[cyclopenta[a]phenanthrene-17,2-furan]-3,5(4h,6h)-dione

(8r,9s,10r,13s,14s,17r)-10,13-Dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-3h-spiro[cyclopenta[a]phenanthrene-17,2-furan]-3,5(4h,6h)-dione

C22H28O3 (340.2038)


   

(9S,14S)-10,13-Dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione

(9S,14S)-10,13-Dimethylspiro[2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthrene-17,5-oxolane]-2,3-dione

C22H28O3 (340.2038)


   

(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide

(E)-N-(diaminomethylidene)-2-methyl-3-[4-methyl-2-[(E)-2-methyl-3-oxo-3-(propan-2-ylideneamino)prop-1-enyl]phenyl]prop-2-enamide

C19H24N4O2 (340.1899)


   

(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid

(E)-5-[4-hydroxy-2-[(E)-3-hydroxyoct-1-enyl]-6-oxooxan-3-yl]pent-3-enoic acid

C18H28O6 (340.1886)


   

2-[(E)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-enyl]benzene-1,4-diol

2-[(E)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-enyl]benzene-1,4-diol

C22H28O3 (340.2038)


   

1-{(E)-amino[(4,6-dimethylquinazolin-2-yl)amino]methylidene}-3-cyclohexylurea

1-{(E)-amino[(4,6-dimethylquinazolin-2-yl)amino]methylidene}-3-cyclohexylurea

C18H24N6O (340.2011)


   

[(10R,13S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate

[(10R,13S,17R)-17-ethynyl-13-methyl-3-oxo-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate

C22H28O3 (340.2038)


   

Myrsinoic acid F

Myrsinoic acid F

C22H28O3 (340.2038)


A member of the class of benzofurans that is 2,3-dihydro-1-benzofuran substituted by a carboxy group at position 5, a prenyl group at position 7 and a 6-methylhepta-2,5-dien-2-yl group at position 2. Isolated from Myrsine seguinii, it exhibits anti-inflammatory activity.

   

cordypyrone A

cordypyrone A

C22H28O3 (340.2038)


   
   

6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile

6-[2-(Dimethylamino)ethylamino]-8-(2-furanyl)-3,3-dimethyl-1,4-dihydropyrano[3,4-c]pyridine-5-carbonitrile

C19H24N4O2 (340.1899)


   

Glycine, N-(N2-L-histidyl-L-lysyl)-

Glycine, N-(N2-L-histidyl-L-lysyl)-

C14H24N6O4 (340.1859)


   

(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

(11S)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

C19H24N4O2 (340.1899)


   

(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

(11R)-11-benzyl-3-oxa-9,14,15,16-tetrazatricyclo[12.2.1.05,9]heptadeca-1(17),15-dien-10-one

C19H24N4O2 (340.1899)


   

mepenzolate

mepenzolate

C21H26NO3+ (340.1913)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

Gly-His-Lys

Gly-His-Lys

C14H24N6O4 (340.1859)


A tripeptide composed of glycine, L-histidine and L-lysine residues joined in sequence.

   

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

6-amino-2-[[2-[(2-aminoacetyl)amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoic acid

C14H24N6O4 (340.1859)


   

17-Hydroxy-3-oxo-17alpha-pregna-1,4-diene-21-carboxylic acid, gamma-lactone

17-Hydroxy-3-oxo-17alpha-pregna-1,4-diene-21-carboxylic acid, gamma-lactone

C22H28O3 (340.2038)


   

Dehydro-dinor-TXB2

Dehydro-dinor-TXB2

C18H28O6 (340.1886)


   
   
   
   
   
   

14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

C22H28O3 (340.2038)


   

(3r,4r)-12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol

(3r,4r)-12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol

C22H28O3 (340.2038)


   

(10s,14r)-14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

(10s,14r)-14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

C22H28O3 (340.2038)


   

(1r,2s,5e,8s,9r)-6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate

(1r,2s,5e,8s,9r)-6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate

C22H28O3 (340.2038)


   

8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

8-hydroxy-2-(1-hydroxyheptyl)-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

C18H28O6 (340.1886)


   

(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

(1r,4s,7r,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

(1r,4s,7s,8s,9r,11s,12s)-12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

2-[5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol

2-[5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol

C22H28O3 (340.2038)


   

(1e,3as,3bs,9ar,9bs,11as)-1-(1-methoxyethylidene)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

(1e,3as,3bs,9ar,9bs,11as)-1-(1-methoxyethylidene)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

C22H28O3 (340.2038)


   

methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[(2r,3r,4ar,5r,8r,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

2-[3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

2-[3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

C22H28O3 (340.2038)


   

7-isopropyl-1,4-dimethyl-3,5,6,7,8,8a-hexahydroazulen-6-yl 4-hydroxybenzoate

7-isopropyl-1,4-dimethyl-3,5,6,7,8,8a-hexahydroazulen-6-yl 4-hydroxybenzoate

C22H28O3 (340.2038)


   

1-[2,4-dihydroxy-6-(8-phenyloctyl)phenyl]ethanone

1-[2,4-dihydroxy-6-(8-phenyloctyl)phenyl]ethanone

C22H28O3 (340.2038)


   

(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

(1s,2s,4z,6r,7r,8s,9r,13r)-6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl 4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C18H28O6 (340.1886)


   

(5r,6r)-6-[(1e,3e,5e,7e,9e,11e)-9,11-dimethyltetradeca-1,3,5,7,9,11-hexaen-1-yl]-5-methyloxane-2,4-dione

(5r,6r)-6-[(1e,3e,5e,7e,9e,11e)-9,11-dimethyltetradeca-1,3,5,7,9,11-hexaen-1-yl]-5-methyloxane-2,4-dione

C22H28O3 (340.2038)


   

(7z,11e)-3-methoxy-7,11,15-trimethyl-5,19-dioxatricyclo[13.3.1.1⁴,¹⁸]icosa-1(18),2,4(20),7,11,16-hexaene

(7z,11e)-3-methoxy-7,11,15-trimethyl-5,19-dioxatricyclo[13.3.1.1⁴,¹⁸]icosa-1(18),2,4(20),7,11,16-hexaene

C22H28O3 (340.2038)


   

12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

12-hydroxy-7-methoxy-2,2,4,9-tetramethyl-5-oxo-6-oxatricyclo[6.3.1.0⁴,¹²]dodecan-11-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

methyl 2-[8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate

(1s,4r,5s,6r,7r,8s,9r,11s,13s)-6,9-dihydroxy-7-methoxy-2,2,9-trimethyl-12-oxatetracyclo[6.3.2.0¹,⁴.0⁵,¹³]tridecan-11-yl acetate

C18H28O6 (340.1886)


   

4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

C22H28O3 (340.2038)


   

methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(4as,5r,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

(4as,5r,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

C22H28O3 (340.2038)


   

(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one

(3z,4r,5s,6s,7r)-3-decylidene-4,5,6,7-tetrahydroxy-4,5,6,7-tetrahydro-2-benzofuran-1-one

C18H28O6 (340.1886)


   

2-[(2e)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol

2-[(2e)-5-(4-methoxy-2,3,6-trimethylphenyl)-3-methylpent-2-en-1-yl]benzene-1,4-diol

C22H28O3 (340.2038)


   

1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol

1-(4-hydroxy-1,3-dihydro-2-benzofuran-1-yl)decane-2,3,4,5-tetrol

C18H28O6 (340.1886)


   

(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2-methylchromene-6-carboxylic acid

(2s)-2-[(3e)-4,8-dimethylnona-3,7-dien-1-yl]-2-methylchromene-6-carboxylic acid

C22H28O3 (340.2038)


   

(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

(2s,4r,8r)-8-hydroxy-2-[(1s)-1-hydroxyheptyl]-5-oxo-2,3,4,6,7,8-hexahydro-1-benzopyran-4-yl acetate

C18H28O6 (340.1886)


   

methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

methyl 2-[(1r,4s,4ar,7r,8r,8ar)-8-(acetyloxy)-4,7-dihydroxy-4,7-dimethyl-octahydronaphthalen-1-yl]prop-2-enoate

C18H28O6 (340.1886)


   

1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate

1-ethyl 4-(2r)-7-[(2r)-6-oxo-2,3-dihydropyran-2-yl]heptan-2-yl butanedioate

C18H28O6 (340.1886)


   

2,7-dimethyl-8-(3-methylbut-2-en-1-yl)-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5,6-dione

2,7-dimethyl-8-(3-methylbut-2-en-1-yl)-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5,6-dione

C22H28O3 (340.2038)


   

(2s)-7-(3-methylbut-2-en-1-yl)-2-[(2e)-6-methylhepta-2,5-dien-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid

(2s)-7-(3-methylbut-2-en-1-yl)-2-[(2e)-6-methylhepta-2,5-dien-2-yl]-2,3-dihydro-1-benzofuran-5-carboxylic acid

C22H28O3 (340.2038)


   

(2s)-2-[(2s,5e)-2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran

(2s)-2-[(2s,5e)-2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran

C22H28O3 (340.2038)


   

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl hexa-2,4-dienoate

C18H28O6 (340.1886)


   

(4as,5s,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

(4as,5s,11bs)-4,4,7,11b-tetramethyl-1h,2h,3h,4ah,5h,6h-phenanthro[3,2-b]furan-5-yl acetate

C22H28O3 (340.2038)


   

[(3as)-1-isopropyl-3a-methyl-3,4,7,8-tetrahydro-2h-azulen-6-yl]methyl 4-hydroxybenzoate

[(3as)-1-isopropyl-3a-methyl-3,4,7,8-tetrahydro-2h-azulen-6-yl]methyl 4-hydroxybenzoate

C22H28O3 (340.2038)


   

12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol

12-ethoxy-11-isopropyl-6-methyl-3-(2-methylprop-1-en-1-yl)-2-oxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),5(13),6,8,10-pentaen-4-ol

C22H28O3 (340.2038)


   

2-[2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran

2-[2-methoxy-6-methyl-7-(4-methylfuran-2-yl)hept-5-en-2-yl]-2,3-dihydro-1-benzofuran

C22H28O3 (340.2038)


   

3,10,10-trimethyl-7-methylidenecycloundeca-3,8-dien-1-yl 4-hydroxybenzoate

3,10,10-trimethyl-7-methylidenecycloundeca-3,8-dien-1-yl 4-hydroxybenzoate

C22H28O3 (340.2038)


   

methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

methyl (1s,3ar,4s,6r,7s,7as)-4-(acetyloxy)-7-formyl-7a-hydroxy-1,3,3,6-tetramethyl-hexahydroindene-1-carboxylate

C18H28O6 (340.1886)


   

(2s)-2-methyl-8-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)chromene-6-carboxylic acid

(2s)-2-methyl-8-(3-methylbut-2-en-1-yl)-2-(4-methylpent-3-en-1-yl)chromene-6-carboxylic acid

C22H28O3 (340.2038)


   

(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

(1s,2s,4e,6r,7r,9r,13r)-7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate

1-ethyl 4-[7-(6-oxo-2,3-dihydropyran-2-yl)heptan-2-yl] butanedioate

C18H28O6 (340.1886)


   

7-(3-methylbut-2-en-1-yl)-2-(6-methylhepta-2,5-dien-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

7-(3-methylbut-2-en-1-yl)-2-(6-methylhepta-2,5-dien-2-yl)-2,3-dihydro-1-benzofuran-5-carboxylic acid

C22H28O3 (340.2038)


   

2-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

2-[(2e,6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

C22H28O3 (340.2038)


   

5-[(2r,3r)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,3-dihydro-2-benzofuran

5-[(2r,3r)-4-(3,4-dimethoxyphenyl)-2,3-dimethylbutyl]-1,3-dihydro-2-benzofuran

C22H28O3 (340.2038)


   

methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

methyl 2-[(2r,3r,4ar,5r,8s,8ar)-3-(acetyloxy)-5,8-dihydroxy-4a,8-dimethyl-octahydronaphthalen-2-yl]prop-2-enoate

C18H28O6 (340.1886)


   

(9r,13s,17s)-8,8,13,17-tetramethyl-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-triene-6,16-dione

(9r,13s,17s)-8,8,13,17-tetramethyl-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-triene-6,16-dione

C22H28O3 (340.2038)


   

(2r)-2,7-dimethyl-8-(3-methylbut-2-en-1-yl)-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5,6-dione

(2r)-2,7-dimethyl-8-(3-methylbut-2-en-1-yl)-2-[(1e)-4-methylpenta-1,3-dien-1-yl]-3,4-dihydro-1-benzopyran-5,6-dione

C22H28O3 (340.2038)


   

2-[(6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

2-[(6e)-3,7-dimethyl-8-(4-methylfuran-2-yl)octa-2,6-dien-1-yl]-5-methylbenzene-1,4-diol

C22H28O3 (340.2038)


   

1-(1-methoxyethylidene)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

1-(1-methoxyethylidene)-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,9bh,10h,11h-cyclopenta[a]phenanthrene-2,7-dione

C22H28O3 (340.2038)


   

6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

6,13-dihydroxy-7-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate

6,10,10-trimethylspiro[bicyclo[7.2.0]undecane-2,2'-oxiran]-5-en-8-yl benzoate

C22H28O3 (340.2038)


   

7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

7,13-dihydroxy-6-methoxy-4,11,11-trimethyl-12-oxatricyclo[6.3.2.0¹,⁹]tridec-4-en-2-yl acetate

C18H28O6 (340.1886)


   

8,8,13,17-tetramethyl-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-triene-6,16-dione

8,8,13,17-tetramethyl-7-oxatetracyclo[10.7.0.0³,⁹.0¹³,¹⁷]nonadeca-1(12),2,4-triene-6,16-dione

C22H28O3 (340.2038)


   

2-(4,8-dimethylnona-3,7-dien-1-yl)-2-methylchromene-6-carboxylic acid

2-(4,8-dimethylnona-3,7-dien-1-yl)-2-methylchromene-6-carboxylic acid

C22H28O3 (340.2038)


   

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl (2e,4e)-hexa-2,4-dienoate

8,9-dihydroxy-2-oxo-10-propyloxecan-3-yl (2e,4e)-hexa-2,4-dienoate

C18H28O6 (340.1886)


   

(10r,14s)-14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

(10r,14s)-14-methoxy-6,6,10-trimethyl-13-oxatetracyclo[9.8.0.0²,⁷.0¹⁴,¹⁹]nonadeca-1(11),2(7),15,18-tetraen-17-one

C22H28O3 (340.2038)